Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle

This article has been Reviewed by the following groups

Read the full article

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic that originated in Wuhan, China, in December 2019 has impacted public health, society, the global economy, and the daily lives of billions of people in an unprecedented manner. There are currently no specific registered antiviral drugs to treat or prevent SARS-CoV-2 infections. Therefore, drug repurposing would be the fastest route to provide at least a temporary solution while better, more specific drugs are being developed.

Article activity feed

  1. SciScore for 10.1101/2020.05.06.081968: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board Statementnot detected.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.
    Cell Line Authenticationnot detected.

    Table 2: Resources

    Experimental Models: Cell Lines
    SentencesResources
    The human lung epithelial cell line Calu-3 2B4 (referred to as Calu-3 cells) was maintained as described (16).
    Calu-3 2B4
    suggested: RRID:CVCL_YZ47)
    Addition of compound to Vero E6 and Calu-3 cells was done in infection medium and in PBS for HAE cultures.
    Calu-3
    suggested: KCLB Cat# 30055, RRID:CVCL_0609)
    Entry inhibition plaque reduction assay: A day before infection Vero E6 cells were seeded in 6-well cell culture plates at a density of 3.5 × 105 cells per well in 2 ml medium.
    Vero E6
    suggested: None
    Software and Algorithms
    SentencesResources
    The 50% effective concentration (EC50), required to inhibit virus-induced cell death by 50%, and the 50% cytotoxic concentration (CC50), that reduces the viability of uninfected cells to 50% of that of untreated control cells, were determined using non-linear regression with GraphPad Prism v8.0.
    GraphPad Prism
    suggested: (GraphPad Prism, RRID:SCR_002798)
    Assessment of potential cytotoxicity of the 48h suramin treatment, compared to PBS treatment, was done with uninfected cells by MTS assay (Promega) and LDH Assay (CytoTox
    CytoTox
    suggested: None

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We found bar graphs of continuous data. We recommend replacing bar graphs with more informative graphics, as many different datasets can lead to the same bar graph. The actual data may suggest different conclusions from the summary statistics. For more information, please see Weissgerber et al (2015).


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • No conflict of interest statement was detected. If there are no conflicts, we encourage authors to explicit state so.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.